Episode Synopsis "Ep 9 - KT Case Study: mRNA Vaccine (ft. Dr. Pieter Cullis)"

How can bench science be translated into the real world? What are other opportunities that are currently available beyond academia? How did collaborations and team building play a role in the development of the COVID-19 mRNA-based vaccines?  Today, join the hosts, Sarah & Isabelle, as they dive into what went into the science of developing the mRNA vaccines (e.g., Moderna, Pfizer) with Dr. Pieter Cullis 🎙 Guest: Dr. Pieter Cullis - Email | Nanomedicines Research Group 👉 Stay connected with Raincoat Podcast - Twitter | Email

Listen "Ep 9 - KT Case Study: mRNA Vaccine (ft. Dr. Pieter Cullis)"

More episodes of the podcast RAINCOAT Conversations

• Ep 10 - KT and Global Security (ft. Carol Dumaine & Dr. Rod Schoonover)
• Ep 9 - KT Case Study: mRNA Vaccine (ft. Dr. Pieter Cullis)
• Ep 8 - Importance of Protecting Ideas during KT (ft. Jon Festinger & Nikos Harris)
• Ep 7 - KT Case Study: COVID-19 (ft. Dr. Bonnie Henry)
• Ep 6 - Knowledge Translation & Communication (ft. Robyn Sussel & Christine Ackerley)
• What is RAINCOAT? ft. Isabelle Rash & Sarah Park
• Ep 5 - Flourishing Partnerships (ft. Ayogo & Digital Health Circle)
• Ep 4 - M4 Trial (ft. Noah Silverberg & Thalia Otamendi)
• Ep 3 - RAD Society - Gear Box (ft. Bill Miller & Tanelle Bolt)
• Ep 2 - Small Steps for Big Changes (ft. Mary Jung & Tineke Dineen)
• Ep 1 - CALMER Project (ft. Liisa Holsti & Manon Ranger)